AU2002225954A1 - Dipeptidylpeptidases and methods of use - Google Patents

Dipeptidylpeptidases and methods of use

Info

Publication number
AU2002225954A1
AU2002225954A1 AU2002225954A AU2595402A AU2002225954A1 AU 2002225954 A1 AU2002225954 A1 AU 2002225954A1 AU 2002225954 A AU2002225954 A AU 2002225954A AU 2595402 A AU2595402 A AU 2595402A AU 2002225954 A1 AU2002225954 A1 AU 2002225954A1
Authority
AU
Australia
Prior art keywords
dipeptidylpeptidases
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002225954A
Inventor
Agnieszka Banbula
Marcin Bugno
Jan S. Potempa
James Travis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc UGARF
Original Assignee
University of Georgia Research Foundation Inc UGARF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc UGARF filed Critical University of Georgia Research Foundation Inc UGARF
Publication of AU2002225954A1 publication Critical patent/AU2002225954A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
AU2002225954A 2000-11-08 2001-11-08 Dipeptidylpeptidases and methods of use Abandoned AU2002225954A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24682700P 2000-11-08 2000-11-08
US60/246,827 2000-11-08
PCT/US2001/046782 WO2002038742A2 (en) 2000-11-08 2001-11-08 Dipeptidylpeptidases and methods of use

Publications (1)

Publication Number Publication Date
AU2002225954A1 true AU2002225954A1 (en) 2002-05-21

Family

ID=22932388

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002225954A Abandoned AU2002225954A1 (en) 2000-11-08 2001-11-08 Dipeptidylpeptidases and methods of use

Country Status (3)

Country Link
US (1) US6864363B2 (en)
AU (1) AU2002225954A1 (en)
WO (1) WO2002038742A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
JP4887139B2 (en) 2003-03-25 2012-02-29 武田薬品工業株式会社 Dipeptidyl peptidase inhibitor
EP1625122A1 (en) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
ZA200602051B (en) 2003-08-13 2007-10-31 Takeda Pharmaceutical 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7790734B2 (en) 2003-09-08 2010-09-07 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
GEP20094679B (en) 2004-03-15 2009-05-10 Takeda Pharmaceuticals Co Dipeptidyl peptidase inhibitors
JP2008501714A (en) * 2004-06-04 2008-01-24 武田薬品工業株式会社 Dipeptidyl peptidase inhibitor
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
EP1799705A4 (en) * 2004-09-23 2008-11-05 Univ Melbourne Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
EP1828192B1 (en) 2004-12-21 2014-12-03 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
NZ538805A (en) * 2005-03-14 2007-10-26 Otago Innovation Ltd Site specific intra-oral application apparatus
RS52110B2 (en) 2005-09-14 2018-05-31 Takeda Pharmaceuticals Co Dipeptidyl peptidase inhibitors for treating diabetes
WO2007033265A1 (en) * 2005-09-14 2007-03-22 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetis
JP5122462B2 (en) 2005-09-16 2013-01-16 武田薬品工業株式会社 Dipeptidyl peptidase inhibitor
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
EA017799B1 (en) * 2006-09-13 2013-03-29 Такеда Фармасьютикал Компани Лимитед Use of 2-[6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8313920B2 (en) * 2008-10-21 2012-11-20 Janssen Research & Development, Llc High-throughput assay for evaluating dipeptidyl peptidase I activity
SG11201809252YA (en) * 2016-04-21 2018-11-29 Sphingotec Therapeutics Gmbh Methods for determining dpp3 and therapeutic methods
EP3263700A1 (en) * 2016-06-30 2018-01-03 Université de Namur Uses of dipeptidyl peptidase 7 (dpp7) polypeptide
US11427814B2 (en) 2019-03-26 2022-08-30 Encodia, Inc. Modified cleavases, uses thereof and related kits
WO2021194908A1 (en) * 2020-03-24 2021-09-30 Encodia, Inc. Modified dipeptide cleavases, uses thereof and related kits

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053547T3 (en) 1986-07-29 1994-08-01 Sunstar Kk REAGENT TO SUBMIT PERIODONTAL DISEASES TO TEST.
US5223404A (en) 1988-01-20 1993-06-29 Sunstar Kabushiki Kaisha Composition for testing periodontal diseases
JPH025580A (en) 1988-06-24 1990-01-10 Canon Inc Superconducting video detecting element
US5824791A (en) 1988-09-08 1998-10-20 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
EP0554314B1 (en) 1990-10-15 1996-08-14 Maude Birgitta WIKSTRÖM A method of determining porphyromonas gingivalis
EP0524906B1 (en) 1991-07-24 2003-04-16 Novartis AG DNA coding for prolylendopeptidase and use thereof
DK38893D0 (en) 1993-03-31 1993-03-31 Novo Nordisk As DNA
US5432055A (en) 1993-06-02 1995-07-11 Univ New York Detection of Porphyromonas gingivalis
US5475097A (en) 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
US6017532A (en) 1993-09-10 2000-01-25 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
US5523390A (en) 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
JPH10501981A (en) 1994-06-23 1998-02-24 日本チバガイギー株式会社 Thermostable prolyl endopeptidase
JP2000507245A (en) 1996-03-22 2000-06-13 ユニバーシティー オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド Immunogenic compositions and methods comprising Porphyromonas gingivalis peptides
WO1997044447A2 (en) 1996-05-03 1997-11-27 President And Fellows Of Harvard College Transcriptional activation system, activators, and uses therefor
US6444799B1 (en) * 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof
WO2000052147A2 (en) 1999-03-05 2000-09-08 University Of Georgia Research Foundation, Inc. Bacterial prolyl peptidases and methods of use

Also Published As

Publication number Publication date
US20020164759A1 (en) 2002-11-07
WO2002038742A2 (en) 2002-05-16
WO2002038742A3 (en) 2003-07-31
US6864363B2 (en) 2005-03-08

Similar Documents

Publication Publication Date Title
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2002211389A1 (en) Microfluidic devices and methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2002323210A1 (en) Bio-synthetic photostimulators and methods of use
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001251358A1 (en) Prion-binding ligands and methods of using same
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2002310237A1 (en) Sponge-derived terpenoids and methods of use
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
EP1263935A4 (en) Scytonemin and methods of using thereof
AU2001268236A1 (en) Use of aicar and related compounds